How many institutions held CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 in Q4 2019?

34 institutional investors reported CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 for Q4 2019. Use the holders table for investor-level position and value details.

Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

Q: What does CUSIP 15117B202 represent in this 13F holders report?

CUSIP 15117B202 is the security identifier for CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 used to aggregate holder disclosures.

CUSIP: 15117B202

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / Common Stock, par value $0.001
Shares outstanding: 80,000,000
Total 13F shares: 3,904,189
Share change: +196,783
Total reported value: $8,706,543
Put/Call ratio: 43%
Price per share: $2.23
Number of holders: 34
Value change: +$447,617
Number of buys: 11
Number of sells: 18

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 15117B202:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.3%	1,026,285	$2,186,000	—	30 Sep 2019	13F
VANGUARD GROUP INC	13F	Company	0.65%	516,118	$1,099,000	—	30 Sep 2019	13F
Cresset Asset Management, LLC	13F	Company	0.57%	457,666	$975,000	—	30 Sep 2019	13F
Meditor Group Ltd	13F	Company	— class O/S missing	420,846	$896,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	0.43%	342,469	$729,000	—	30 Sep 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.42%	334,856	$713,000	—	30 Sep 2019	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.32%	256,308	$547,000	—	30 Sep 2019	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	147,300	$314,000	—	30 Sep 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	103,193	$219,000	—	30 Sep 2019	13F
Invesco Ltd.	13F	Company	0.05%	41,997	$89,000	—	30 Sep 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.05%	40,453	$86,000	—	30 Sep 2019	13F
WINTON GROUP Ltd	13F	Company	0.04%	33,661	$72,000	—	30 Sep 2019	13F
NORTHERN TRUST CORP	13F	Company	0.04%	29,427	$63,000	—	30 Sep 2019	13F
Stratos Wealth Partners, LTD.	13F	Company	0.03%	25,000	$53,000	—	30 Sep 2019	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.03%	20,397	$43,000	—	30 Sep 2019	13F
A.R.T. Advisors, LLC	13F	Company	0.02%	19,741	$42,000	—	30 Sep 2019	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	17,837	$38,000	—	30 Sep 2019	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.02%	16,940	$36,000	—	30 Sep 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.02%	16,719	$36,000	—	30 Sep 2019	13F
Virtu Financial LLC	13F	Company	0.02%	13,993	$30,000	—	30 Sep 2019	13F
Creative Planning	13F	Company	0.02%	12,566	$27,000	—	30 Sep 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.02%	12,026	$26,000	—	30 Sep 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.01%	10,657	$23,000	—	30 Sep 2019	13F
HighTower Advisors, LLC	13F	Company	0.01%	11,275	$21,000	—	30 Sep 2019	13F
MORGAN STANLEY	13F	Company	0.01%	9,446	$20,000	—	30 Sep 2019	13F
Tekla Capital Management LLC	13F	Company	0.01%	7,053	$15,000	—	30 Sep 2019	13F
UBS Group AG	13F	Company	0.01%	4,675	$10,000	—	30 Sep 2019	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	4,183	$8,000	—	30 Sep 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	2,486	$5,000	—	30 Sep 2019	13F
Realta Investment Advisors	13F	Company	0%	1,925	$4,000	—	30 Sep 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0%	1,796	$4,000	—	30 Sep 2019	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0%	1,774	$4,000	—	30 Sep 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	1,668	$4,000	—	30 Sep 2019	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0%	1,062	$2,262	—	30 Sep 2019	13F
Geneos Wealth Management Inc.	13F	Company	0%	1,333	$2,000	—	30 Sep 2019	13F
Rehmann Capital Advisory Group	13F	Company	0%	508	$1,082	—	30 Sep 2019	13F
ROYAL BANK OF CANADA	13F	Company	0%	556	$1,000	—	30 Sep 2019	13F
BSW Wealth Partners	13F	Company	0%	448	$1,000	—	30 Sep 2019	13F
Advisor Group, Inc.	13F	Company	0%	252	$1,000	—	30 Sep 2019	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	256	$545	—	30 Sep 2019	13F
Kelly Financial Services LLC	13F	Company	0%	46	$98	—	30 Sep 2019	13F
EVOKE WEALTH, LLC	13F	Company	0%	8	$17	—	30 Sep 2019	13F

Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) as of Q4 2019

As of 31 Dec 2019, Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,904,189 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Cresset Asset Management, LLC, TSP Capital Management Group, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 34 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

-6

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.